期刊文献+

凝血因子Ⅷ C2结构域表达载体的构建及其在真核细胞NIH3T3中的表达

Construction of recombinant vector containing FⅧ-C2 and its expression in NIH3T3 cells
下载PDF
导出
摘要 目的 :构建人凝血因子 F 中具有免疫活性的 C2结构域表达载体并通过真核宿主细胞表达出多肽。方法 :从 HEK2 93细胞提取总 RNA,经 RT- PCR扩增获得目的片段。将该片段与信号肽共同构建在同一表达载体 ,并在 NIH 3T3细胞中表达 ,Western blotting检测。结果 :经限制性酶切鉴定和测序分析证实 ,采用 RT- PCR成功地完成 F - C2 c DNA的扩增和表达载体的构建 ,重组载体转染进入 NIH 3T3细胞后 ,经检测培养上清中的蛋白成分证实 ,成功地表达出 F - C2结构域多肽。结论 :重组表达载体的构建是表达出分泌型 F C2多肽的一种可行的方法。 Objective To construct the complementary DNA (cDNA) of FⅧ-C2 by gene engineering and express the biologically active domain in NIH 3T3. Methods The total RNA extracted from 293 cells and FⅧ-C2 was amplified by RT-PCR. The product was then inserted into pTARGET vector together with signal peptide sequence. The recombinant vector was transfected into NIH3T3 cells followed by the detection of the expression of FⅧ-C2 by Western blotting. Results The cDNA of FⅧ-C2 was identified correctly by endonucleases cleavage and sequencing. The recombinant FⅧ-C2 peptide was obtained by detection of FⅧ-C2 from the supernatant of NIH3T3. Conclusion The construction of recombinant vector is a feasible way to express secretive FⅧ-C2.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2005年第1期35-38,63,共5页 Journal of Jilin University:Medicine Edition
基金 中国博士后科学基金资助课题 (2 0 0 3)
关键词 因子Ⅷ C2结构域 逆转录聚合酶链反应 基因重组 factor Ⅷ C2 domain reverse transcriptase polymerase chain reaction gene recombination
  • 相关文献

参考文献11

  • 1Jarvis MA, Levin LG, Harrison JA, et al. Induction of human factor Ⅷ inhibitors in rats by immunization with human recombinant factor Ⅷ: a small animal model for humans with high responder inhibitor phenotype [J]. Thromb Heamost,1996, 75(2): 318-325.
  • 2Sehon AH, Lang G. Avoiding unwanted immune responses to novel gene products[J]. J Liposome Res, 2002,12:199-204.
  • 3Ananyeva N, Khrenov A, Darr F, et al. Treating haemophilia A with recombinant blood factors: a comparison[J]. Expert Opin Pharmacother, 2004, 5 (5): 1061 - 1070.
  • 4Vehar GA, Keyt B, Eaton D, et al. Structure of human factor Ⅷ[J]. Nature, 1984,312, 337-342.
  • 5Mann KG, Nesheim ME, Church WR, et al. Surfacedependent reactions of the vitamin K-dependent enzyme complexes[J]. Blood, 1990,76:1-16.
  • 6Berntrop E. Second generation, B-domain deleted recombinant factor Ⅷ [J]. Thromb Haemost, 1997, 78: 256-260.
  • 7Lin Y, Yang X, Chevrier MC, et al. Relationships between factor Ⅷ: Ag and factor Ⅷ in recombinant and plasma-derived factor Ⅷ concentrates [J]. Haemophilia, 2004, 10 (5): 459-469.
  • 8Spiegel PC, Jacquemin M, Saint-Remy JMR, et al. Structure of a factor Ⅷ C2 domain-immunoglobulin G4k Fab complete:identification of an inhibitory antibody epitope on the surface of factor Ⅷ [J]. Blood, 2001, 98 (1): 13-19.
  • 9Shima M, Scandella D, Yoshioka A, et al. A factor Ⅷ neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor Ⅷ binding to yon Willebrand factor and to phosphatidylserine [J]. Thromb Haemost, 1993, 69: 240-246.
  • 10Chen C, Fang XD, Zhu J, et al. The gene expression of coagulation factor Ⅷ in mammalian cell lines [J]. Thromb Res, 1999, 95 (2): 105-115.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部